Home / Recalls / Medical Devices
Qiagen Sciences LLC recalls therascreen FGFR RGQ RT-PCR kit (US IVD) REF 874721
Recalled September 7, 2022 · FDA recall Z-1650-2022 · Qiagen Sciences
Hazard
Increased occurrence rate of false positive results, lead to a false positive sample result that could subsequently be incorrectly reported from the laboratory. A false positive result could lead to the risk of the patient being exposed to an inappropriate or suboptimal anti-cancer treatment and/or unnecessarily experiencing side effects · FDA Class II
Units
22 kits
Sold at
IN, NC, MN, TX Foreign: Belgium, China, Germany, Jordan, Italy, Netherlands, Malaysia, Spain, Thailand
Description
Increased occurrence rate of false positive results, lead to a false positive sample result that could subsequently be incorrectly reported from the laboratory. A false positive result could lead to the risk of the patient being exposed to an inappropriate or suboptimal anti-cancer treatment and/or unnecessarily experiencing side effects
Product
therascreen FGFR RGQ RT-PCR kit (US IVD) REF 874721
Manufacturer(s)
Qiagen Sciences LLC
Source: U.S. Food and Drug Administration. Official recall notice on fda.gov →